Abstract
Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutrients consumption, feed medium containing multiple components in cell culture can affect the characteristics of cell growth and improve the yield and quality of recombinant protein. Fed-batch optimization should have a connection with comprehensive factors such as culture environmental parameters, feed composition, and feeding strategy. At present, process intensification (PI) is explored to maintain production flexible and meet forthcoming demands of biotherapeutics process. Here, CHO cell culture, feed composition in fed-batch culture, fed-batch culture environmental parameters, feeding strategies, metabolic byproducts in fed-batch culture, chemostat cultivation, and the intensified fed-batch are reviewed.
Key points
• Fed-batch culture in CHO cells is reviewed.
• Fed-batch has become a common technology for recombinant protein production.
• Fed batch culture promotes recombinant protein production in CHO cells.
Similar content being viewed by others
Introduction
In recent years, with the growing demand for recombinant therapeutic proteins (RTPs) in the pharmaceutical market, including recombinant antibody, the production of RTPs has developed rapidly. More than 120 recombinant antibodies have been approved by the European Medicines Agency (EMA) and the U.S Food and Drug Administration (FDA) with thousands of billion dollars in market value (Kaplon et al. 2020). A report has estimated that market value about monoclonal antibodies (mAbs) will has reached over US$ 300 billion by 2025 (Lu et al. 2020). Among the recombinant protein expression system, Chinese hamster ovary (CHO) cells are the preferred cells for RTP production (Ritacco et al. 2018; Gupta et al. 2021) due to several advantages: ① not susceptible to human virus infection with high safety (Lalonde and Durocher 2017); ② RTPs with post- translational modifications similar to those of human cells (Stach et al. 2019); ③ high-density CHO cells can accommodate suspension culture with the chemically defined serum-free medium (CD-SFM) and produce proteins that secrete into the culture medium (Ritacco et al. 2018; Dahodwala and Lee 2019).
Nowadays, mAbs production in mammalian cell culture is mainly performed with fed-batch processes in large-scale bioreactors (Schellenberg et al. 2022). CHO cells are usually cultivated in a fed-batch mode to achieve maximum cell density and product titer, with either continuous or bolus feed addition (Romanova et al. 2022). The initial cellular growth is supported by the basal medium. Concentrated feed medium is added in fed-batch culture to replenish nutrients and prolong the culture time (Ritacco et al. 2018; Chee Furng Wong et al. 2005). Feed medium can avoid the nutrients limitation, and it can promote higher production of recombinant proteins (Rish et al. 2022; Bibila and Robinson 1995; Lu et al. 2013). The culture time of cells in stationary phase after fed-batch treatment is longer than that of batch culture (Sellick et al. 2015). Fed-batch culture requires an understanding of the characteristics of cell growth and cell metabolism, and the key process parameters that affect the quality and yield of RTPs (Ghaffari et al. 2020). CHO cell grows at a high speed in exponential phase, with an accelerated consumption of glucose and amino acids, resulting in accumulation of lactate and ammonium (Horvat et al. 2020; Zagari et al. 2013). In fed-batch culture, temperature, pH, and other process parameters also have an impact on antibody expression and quality attributes (Kuwae et al. 2018; Pan et al. 2017; Graham et al. 2019). Fed-batch culture can improve the expression and production of RTPs in CHO cells, but traditional bolus feed delivery also causes accumulation of metabolic byproducts (Xiao et al. 2021). Therefore, a reasonable feeding strategy is quite important (Baik et al. 2015; Zhang et al. 2013; Mellahi et al. 2019). Fed-batch culture has focused on reducing the cost of RTP production, which has become the research focus in pharmaceutical industry (Ghaffari et al. 2020).
CHO cell culture
Adherent CHO cell grows under DMEM/F12 medium containing 10% fetal bovine serum (FBS) at 37℃, 5% CO2 (Li et al. 2021). SFM is chosen to suspension culture, supporting a transition from adherent culture to suspension culture mode. The basal medium is used for the adherent culture including serum components from fetal bovine. Serum components are complex, and it is prone to contamination (Lalonde and Durocher 2017). SFM is divided into ordinary serum-free medium, xeno-free medium, animal-free medium, protein-free medium, and chemically defined serum-free medium (Gélinas et al. 2019; Yao and Asayama 2017). When it comes to cell suspension culture, SFM can effectively avoid disadvantages caused by serum culture, such as contamination and difficulty in purification.
Batch culture refers to a culture method that can harvest recombinant proteins at one time after adding SFM once. Due to short culture time and unsatisfactory cell density at the time of sample collection, RTP production is unideal. Fed-batch mode improves RTP production. It is reported that mAb titer in fed-batch culture has reached more than 10 g/L (Handlogten et al. 2018; Kelley 2009). In recent years, fed-batch process has become an important production process for the large-scale production of RTPs. However, maintaining high productivity of cells and quality attributes of protein is still a challenge. Therefore, fed-batch culture has shifted from the high-yield recombinant protein merely to the dual goals of high-yield and high-quality production (Ha et al. 2022).
Feed composition in fed-batch culture
Optimizing the critical feed composition and the concentrations of components are crucial to process development (Zou et al. 2020). In fed-batch industry, Raman spectroscopy with partial least squares regression (PLSR) or multiple linear regression (MLR) are applied to monitor and control the concentrations of glucose and amino acids (Kozma et al. 2018). Besides Raman spectroscopy, liquid chromatography-mass spectrometry (LC–MS) has been considered to analyze amino acids and inorganic salt (Hoang et al. 2021). For the first time, lipidomics analysis has been performed for lipid identification and lipid quantitation in fed-batch culture (Ali et al. 2018). In addition, feed composition has been linked with cell metabolism regulation to demonstrate fed-batch culture (Braasch et al. 2021) (Fig. 1).
The components of feed medium are similar to SFM, including amino acids, carbon sources, inorganic salts, trace elements, vitamins, lipids, and putrescine and yeast hydrolysate etc. (Table 1).
Amino acid
During upstream process optimization, amino acid is one of the major concerns (Fan et al. 2015). Amino acids deplete in batch culture, which is detrimental to RTP production (Ghaffari et al. 2020). Amino acids’ feeding is related with tricarboxylic acid cycle (TCA cycle) (Rish et al. 2022). The TCA cycle depends on alternative metabolites to complement intermediates (Hong et al. 2018; Ghorbaniaghdam et al. 2014). Amino acids consumed from feed medium can be directed to the TCA cycle by conversion between the cytosol and the mitochondria. Furthermore, the catabolism of amino acids is supply for the TCA cycle. Amino acids in feed medium are limited. AMP that leads to boosting cell health is associated with the purine nucleotide cycle. Malate and glycine accumulation are from the TCA cycle. Cell proliferation has a negative impact with ammonia concentrations above 5 mM (Yang and Butler 2000), and ammonia is derived from the hydrolysis of amino acids (Rish et al. 2022). Thus, controlling feeding of amino acids may reduce byproducts accumulation (Rish et al. 2022). Although cells can synthesize non-essential amino acids, cell growth, and the expression of recombinant proteins still rely on amino acids in feed medium (Horvat et al. 2020).
N-lactoyl-leucine (Lac-Leu) and N-lactoyl-isoleucine (Lac-Ile) can replace unmodified leucine and isoleucine, respectively. Lac-Leu and Lac-Ile improved the solubility in culture medium. Adding 2 × concentrated feed medium with a 70% mixture of two above-mentioned N-Lactoyl amino acids (Lac-AA) increased the yield of recombinant protein by 58%, compared with the addition of 1 × concentrated feed medium. Schmidt et al. found that 2 × concentrated medium reduced the volume of feed medium (Schmidt et al. 2021). According to metabolic flux analysis (MFA), Xing et al. optimized feed medium to produce antibody fusion protein (B1) in CHO cells. The concentration of alanine, arginine, glutamine and glycine were reduced, while the concentration of methionine, tryptophan, asparagine and serine were increased. Finally, B1 protein titer was ameliorated by 27% in fed-batch culture (Xing et al. 2011). Fouladiha et al. used the computational modeling method to design a feeding strategy in CHO cells. To study the effect of the production of mAb in CHO cells, 15 metabolites were analyzed by Plackett – Burman (PB) design. The results showed that the production of mAbs could be significantly improved by 2 times after threonine treatment (Fouladiha et al. 2020). Hecklau et al. reported that S-sulfo-L cysteine (SSC) replaced cysteine and was highly stable in fed-batch culture; feed medium supplemented with SSC prolonged cell viability and enhanced product titers by 78%. Meanwhile, this strategy reduced ammonium (NH4+) accumulation (Hecklau et al. 2016). Zhang et al. took advantage of high concentration tyrosine and low concentration tyrosine experimental groups, and they cultured CHO cells expressing anti-CD20 IgG1 in bioreactor. Apart from feed medium containing tyrosine, 88 mM tyrosine solution was added in the high concentration tyrosine group. High concentration tyrosine promoted the cell growth and reduced the osmolality of bioreactor culture environment and increased the production of mAbs (Zhang et al. 2020a).
Amino acids are key components of feed medium, and their concentration and properties can affect yield and quality of RTPs in fed-batch culture. Amino acids involved in fed-batch culture require a strict design. However, some high concentration amino acids are easy to precipitate due to the limitation of the solubility. Modified amino acids are based on the original structure. We need to comprehensively consider the characteristics of CHO cells and establish the best addition strategy.
Carbon source
Glucose is the primary carbon source of the TCA cycle in exponential phase, and glucose consumes fast at the later stage of the exponential phase (Kirsch et al. 2022). However, glucose consumption causes accumulation of pyruvate and lactate, which leads to inhibition of cell growth. Wilkens et al. found that 3.6 g/L glucose concentration shortened CHO cell culture time and lactate concentration attained 2.7 g/L after 120 h. Although both 1.08 g/L glucose and 2.52 g/L galactose are applied to diminish accumulation of lactate, and tissue plasminogen activator (t-PA) production was increased to 100% when 1.08 g/L glucose and 2.52 g/L galactose was added to CHO cell culture, final concentration of glucose approached zero after 160 h and cell viability was decreased (Wilkens et al. 2011). During the cell culture, the minimum glucose concentration needs to be controlled at 2 ~ 3 g/L (Sun et al. 2021).
Glutamine is the secondary carbon source in the early exponential phase of cells, but it increases lactate levels (Kirsch et al. 2022). It was found that the expression of Fc-fusion protein in CHO cells was increased by 43% and the total sialic acid content of cells was increased by 37% when galactose was supplemented with 40% replacement ratio and glucose carbon source was replaced (Xiao et al. 2019). CHO cells transfected with GLUT5 fructose transporter were cultivated in fed-batch culture system, and feed medium containing 14.5 g/L fructose was added. Fructose improved cell growth, and it decreased accumulation of lactate. Wlaschin et al. indicated that CHO cells had an ability to replace carbon source through the expression of GLUT5 fructose transporter (Wlaschin and Hu 2007).
According to the glucose content in the culture medium, the high concentration glucose solution can be added to the CHO cell culture medium. Because the high concentration of carbon source also leads to metabolic byproducts accumulation, so the concentration of carbon source should be strictly controlled. Proper alternative carbon sources can avoid inhibition of cell growth by byproducts after glucose consumption.
Inorganic salts and trace elements
Fed-batch culture also requires inorganic salts to regulate pH and osmolality in cell culture environment. Zhu et al. used 2L bioreactor for fed-batch culture, and they added Na+ to control osmolality and partial pressure of CO2 (pCO2). Both 140 ~ 160 mmHg pCO2 and 400 mOsm/kg osmolality decreased the viable cell density (VCD) of CHO cells by 18%, but these factors clearly augmented the production of protein B1 (Zhu et al. 2005). In cell culture, selenium (Se) in the form of selenite can protect cells from oxidative damage. Zhang et al. found that the VCD exceeded 1 × 107 cells/mL and product titer of approximately 3 g/L was achieved in 14-day fed-batch cultures with the addition of selenite (Zhang et al. 2006).
Gangwar et al. found that Zn, Cu, Fe, and Mn impact charge heterogeneity, and reduce accumulation of metabolic byproducts in cell culture. Fe, Mn, and Ni enhance the acidic variants while Cu inhibits it. Zn reduces the basic variants (Gangwar et al. 2021). Chung et al. found that Ferrous sulfate (Fe2+) in feed medium stored for 7 weeks can reduce the charge heterogeneity, but it improved the yield of mAb expressed by CHO cells (Chung et al. 2019). Graham et al. found that both 50 and 100 μM zinc ions (Zn2+) added in bioreactor promoted the production of β-Glucuronidase (GUS) in CHO cells and harvested 2 times increase in specific activity of GUS (Graham et al. 2020). 5 μM copper sulfate (Cu2+) in feed medium obtained the final mAb titer of 11.9 ± 0.6 g/L to express IgG1 in CHO cells, which was 4.8 times higher than the final mAb titer of conventional fed-batch culture (Xu et al. 2016).
Vitamin
Vitamin enhances productivity in CHO cells, and impacts charge heterogeneity. Gangwar et al. also indicated that vitamins can inhibit the acidic variants while it enhances the basic variants (Gangwar et al. 2021). Hou et al. found that increasing rate of vitamin C and nicotinamide feeding can reduce the phosphorylation level in CHO cells to 3% and attenuated the hydroxylation level to 9.4% (Hou et al. 2019). Adding B vitamins including 0.005 g/L vitamin B2, 0.0035 g/L pyridoxine (vitamin B6), 0.03 g/L pyridoxal (vitamin B6), 0.0985 g/L folic acid and 0.024 g/L vitamin B12 can improve packed cell volume (PCV) and antibody titer (Vijayasankaran et al. 2013). Lee et al. added 10 g/L vitamin K solution prepared with 13% polysorbate 20 (PS20) in 4-day fed-batch culture for cultured CHO cells expressing recombinant human factor II (rhFII). When the final concentration of vitamin K was 0.1 mg/L, gamma-carboxyglutamate (Gla) level was decreased (Lee et al. 2017a).
Lipid
Ethanolamine is one of the components of the phospholipid structure in mammalian cell membranes (Spens and Häggström 2007). As for TNFR-Fc production in CHO cells, the addition of the feed medium supplemented with ethanolamine and lipids resulted in a maximum VCD of 4.3 × 106 cells/mL and the antibody titer of 378 mg/L, which was threefold higher than batch culture (Zhang et al. 2013). Therefore, lipid can appropriately supplement in feed medium.
Other components
Putrescine is essential for cell growth (Jänne et al. 2004). Zhang et al. confirmed that putrescine was designed by PB design and it sharply increased mAb production. A significant increase in TNFR-Fc production was observed after adding feed medium with the concentration of 41.67 mg/L of putrescine (Zhang et al. 2013). Jardon et al. found that autophagy negatively affected recombinant proteins production. The autophagy inhibitor 3-methyl adenine (3-MA) in fed-batch culture resulted in a 2.8-fold increase in t-PA production compared with control group without 3-MA (Jardon et al. 2012). Autophagy-inducing peptide (AIP), a derivative of the autophagy protein Beclin 1, facilitated the production of mAbs in CHO cells by regulating cellular autophagy. The addition of 3 µM of AIP in fed-batch culture ameliorated the expression level of human IgG1, and IgG1 concentration exceeded 1200 µg/mL (Braasch et al. 2021). The yield of Fc-fusion protein (Fc) in fed-batch culture raised twofold by Yeast hydrolysate (YE), and YE also increased CHO cells size and intracellular nucleotide content (Hu et al. 2018). CHO cells expressing human mAb and Fab fragments were cultivated in 14-day fed-batch culture, and the concentration of 25 mg/L deoxyuridine was added at day 2. VCD and protein production were increased. Takagi et al. harvested 9.2 g/L human mAb and over 4 g/L Fab fragment antibody with deoxyuridine, thymidine, and deoxycytidine (Takagi et al. 2017). Since deoxyuridine, thymine, and deoxycytidine are all pyrimidine nucleotides, exogenous nucleoside may give a platform for efficient antibody production by providing nucleosides precursors through the remedial synthesis pathway of pyrimidine nucleotides. Aki et al. screened 4-(2,5-dimethyl-1H-pyrrol-1-yl) -N- (2,5-dioxopyrrolidin-1-yl) benzamide (MPPB). The mAb concentration of MPPB treatment was increased to 1098 mg/L, which was 1.5-fold higher than the mAb concentration of control group (Aki et al. 2021). Further studies in fed-batch culture facilitate the development of more additives, besides these above components.
Fed-batch culture environmental parameters
Culture parameters can affect CHO cell growth, recombinant protein expression, protein glycosylation, cell metabolites, and other factors (Butler 2005). Bioreactors are designed for the cultivation of suspension culture for RTP production in CHO cells (Schmid et al. 2022). Cells are expanded by the cryovial or shake flask, and then grows in bioreactor (Hernández Rodríguez and Frahm 2020; Schmid et al. 2022). For fed-batch culture, culture environmental parameters in bioreactor are usually optimized through design-of-experiments (DoE) or one-factor-at-a-time (OFAT) studies, like temperature, dissolved oxygen (DO), and pH (Weng et al. 2020; Schneider et al. 2019).
Culture temperature
Culture temperature downshifting is generally performed in exponential growth phase. The culture temperature is switched from 37 ℃ to a lower temperature ranged from 29 ℃ to 35 ℃ for the sake of decreasing cell apoptosis and promoting antibody synthesis (Moore et al. 1997; Kou et al. 2011). Low temperature has a positive impact on integral cell density, cell viability, and cell-specific productivity (McHugh et al. 2020).
Torres et al. cultured CHO cell expressing human erythropoietin (hEPO) using a fed-batch culture process. They observed that low temperature not only had the advantage of improving the specific productivity of CHO cell expressing recombinant proteins, but also significantly increased the gene encoding the specific transcription activator of unfolded protein response, reducing the possibility of protein degradation; Hypothermia also enhanced the expression of hEPO by regulating the cell cycle (Torres et al. 2021). Cell culture temperature can significantly affect the VCD and protein expression in CHO cells. When CHO cells expressing anti-CD20 mAb were cultured at 35 °C, 33 °C, and 31 °C with the addition of feed medium at days 3, 6, and 9, 35 °C can increase cell density and expression of anti-CD20 mAb (Kong et al. 2020). Stiefel et al. that the effect of shifting temperature from 37 °C to 30 °C on miRNA expression in CHO cells was investigated. Low temperature condition increased IgG production through upregulating the expression of miRNAs related with inhibition of apoptosis, promotion of cell growth and protein production in CHO cells (Stiefel et al. 2016). Thus, low temperature is one of the most normal factors of cell culture.
Osmolality
Nutrient supplementation and metabolic byproducts accumulation are able to increase extracellular osmolality at the late stages of culture in fed-batch culture (Alhuthali et al. 2021). Both nutrient and alkaline supplemented can increase the osmolality of the culture environment (Ha et al. 2022). In fed-batch process, NaCl maintained high osmolality. It increased the titer of mAb, reduced galactosylation, and increased the proportion of high-mannose glycosylation (man5) (Qin et al. 2019). Xiao et al. found that continuous feeding resulting in osmolality below 450 mOsm/kg reduced the high-mannose glycosylation to less than 5% and increase the yield of mAb to 10 g/L (Xiao et al. 2021). Lee et al. investigated the effect of high osmolality on protein glycosylation in CHO cells. Osmolality reached over 400 mOsm /kg after adding betaine, and Fc-fusion protein sialylation in CHO cells decreased (Lee et al. 2017b). Inorganic salt and high feed volume can lead to high osmolality in fed-batch culture. Although high osmolality increased the cell-specific productivity (qp) of CHO cells, but it increased the proportion of high mannose and inhibited the growth of CHO cells. Romanova et al. launched proteome study of hyperosmolality-exposed CHO cells together with control cells, and harvested cell samples at days 2, 6, and 8 in fed-batch culture, respectively. Whole protein lysates of hyperosmolality-exposed cell group and control cell group sampled on days 2, 6, and 8 were analyzed by western blot. Septins protein was obviously up-regulated by about 2-threefold at day 6 after treated with hyperosmolality, and up-regulated about 1-threefold at day 8 (Romanova et al. 2022).
Exposure of CHO cell to highly concentrated feed medium causes an increasing osmolality over 300 mOsm/kg in respect of cell physiology, morphology, and proteome (Romanova et al. 2022). In fed-batch culture, appropriate additives can obtain feasible osmolality. Furthermore, an available feeding strategy is also used for avoiding hyperosmolality.
pH
The pH of cell culture requires optimization to produce high-quality recombinant protein. The pH of CHO cell growth ranges from 7.2 to 7.6 (Michl et al. 2019). CHO cells expressing mAb against vascular endothelial growth factor (VEGF-MA) were cultured in 3 L bioreactor and the culture conditions were optimized. The pH was adjusted by adding sodium bicarbonate. When the pH value was set to 7.10, the yield of VEGF-MA increased to 4.1 g/L, and the charge heterogeneity, glycosylation level and protein purity were 26.1%, 59.1%, and 95.1% respectively (Feng and Shi 2020). It is necessary to follow the standard pH range of CHO cells when it comes to designing the pH in fed-batch culture. If the pH of cell culture maintains below 6.8 or above 7.6, CHO cell growth is negatively affected. The pH of cell culture is usually interactively regulated by CO2 and inorganic salts to improve CHO cell growth, which can achieve large-scale recombinant proteins production.
Dissolved oxygen
DO is one of the key environmental parameters in large-scale process, which affects cell growth and recombinant protein production (Chotigeat et al. 1994; Restelli et al. 2006). Most of DO values in CHO cells are usually in the range of 20 to 50% (Fleischaker and Sinskey 1981). Ventini et al. reported that the final recombinant thyroid-stimulating hormone (rTSH) titer was 1.6 mg/L when DO value was 20% in fed-batch culture mode (Ventini et al. 2011). To improve the yield and quality of human IgG1 mAb, Mahé et al. adjusted the DO value to 40%, and CHO cells expressing human IgG1 mAb were cultured in fed-batch culture supplied with Copper Acetate and Ferric Citrate. The yield of mAb reached more than 10 g/L in 14 days fed-batch culture, Copper Acetate and Ferric Citrate diminished man5 content and acidic charge variants of mAb and increased the proportion of G1F (Mahé et al. 2022).
Feeding strategy
In addition to adjusting the composition of feed medium and setting reasonable process parameters, it is necessary to design and develop available feeding strategy to produce the high-yield and high-quality of recombinant proteins (Horvat et al. 2020). The control criterion and the mode of feeding should be taken into consideration in the aspect of feeding strategy. Keeping the concentration of one or two main nutrients at an ideal level is completed by control criterion. According to the stoichiometric feed composition, the rest of nutrients are added to culture system (Costa et al. 2014). Feeding strategy is usually divided into two addition methods: continuous feeding and bolus feeding. Bolus feeding has the advantages of simple operation, low facility requirements and low production costs. Bolus feed delivery strategy increases the expression of mAbs in CHO cells and is the most widely used fed-batch culture method for large-scale mammalian cell culture. However, the addition of a large amount of feed medium leads to accumulation of metabolic byproducts and the increase of osmolality. Continuous feeding can deal with two problems above, and it can adjust the feeding rate to maintain the concentration of nutrients, which is based on the nutrients consumption. Therefore, continuous feeding has more advantages in the aspect of cell culture (Xiao et al. 2021; Kamachi and Omasa 2018).
To promote the high expression of anti-HER2 mAb in CHO cells, Feed 4 was added at 5% of the initial culture volume at days 3, 5, 7, and 9. Peak VCD was 17.1 × 106 cells/mL in fed-batch culture and mAb yield reached 437 mg/L (Yuan et al. 2020). In order to improve the expression of human mouse chimeric anti epidermal growth factor receptor variant III (EGFR vIII) antibody C12 in CHO cells, continuous feeding strategy was adopted and feed medium was added to the bioreactor from day 3. Compared with bolus feeding methods, the continuous feeding method reduced the ratio of cell metabolic byproducts, culture osmolality and high mannose type, improved the VCD and viability of CHO cells, and the antibody production exceeds 10 g/L (Xiao et al. 2021). Horvat et al. used continuous feeding to optimize fed-batch culture process to culture CHO cells. From day 4, glucose solution with a concentration higher than 400 g/L was supplemented to keep final glucose concentration less than 5.55 mmol/L. From day 5, feed medium containing serine was continuously added (Horvat et al. 2020). Continuous feeding can reduce the osmolality and mannosylation ratio of the cell culture, but it increased the mAb yield. If the VCD and cell viability of CHO cells show a downtrend in the late exponential phase or in the early stationary phase, feed medium should be added in cell culture. Great feed strategy has a positive impact on RTP production.
Monitoring and control system is introduced in fed-batch culture, which maintains key cellular nutrients at an ideal level. Bolus feed delivery strategy is widely used for fed-batch culture, but it cannot adjust the medium concentration to the dynamic nutrient consumption rate of cells at different metabolic stages (Xie and Wang 1994a, b).
Raman spectroscopy is used for monitoring nutrient and byproducts (glucose, lactate, and amino acid) (Domján et al. 2022). Dynamic feeding strategies are used to control the delivery of feed medium via Raman spectroscopy. In an early phase of the development, Domján et al. established a partial least squares (PLS) calibration model that took the cell metabolic behavior and nutritional consumption into account. Subsequently, the nutrients are maintained at the desired level (Domján et al. 2022). For mAb production in CHO cells, Eyster et al. developed Raman spectroscopy to control lactate and glucose in fed-batch culture, and established PLS model for predicting glucose and lactate concentrations. Three feeding strategies were evaluated in terms of cell metabolism, productivity, and product quality. Ammonium levels were reduced by 68% through controlling lactate at 2 g/L, while mAb galactosylation levels were increased by approximately 50% (Eyster et al. 2021) .
Metabolic byproducts in fed-batch culture
In the late stages of cell culture, fed-batch culture usually stores byproducts such as lactate and ammonium (Brunner et al. 2017; Fan et al. 2015). High concentrations of metabolic byproducts are detrimental to cell growth and antibody expression (Torres et al. 2018; Zhang et al. 2019; Konakovsky et al. 2016; Karengera et al. 2018). Glucose is transferred to the cytoplasm by transport protein GLUT1 in CHO cells, and a large amount of pyruvate is generated through glycolysis. Part of pyruvate using lactate dehydrogenase is further converted to lactate (Li et al. 2012). To culture CHO cells expressing Fc-fusion protein and reduce lactate accumulation in fed-batch culture, galactose is used as a carbon source to reduce accumulation of lactate (Xiao et al. 2019). CHO-K1 cells expressing anti-HIV antibody VRC01 were cultured in fed-batch culture. Feed medium was added daily starting from day 3. After 12 h of cell inoculation, 10 mM and 30 mM NH4Cl were added to the CHO cell culture medium. Compared with the control group, VCD and culture time of group treated with 30 mM NH4Cl were significantly reduced, and byproducts including lactate, glucose, ammonium, and glutamine were accumulated. Particularly, ammonium had a negative impact on antibody titer and cell-specific productivity (Chitwood et al. 2021).
The addition of TCA cycle intermediates including alpha-ketoglutarate (α-KG), malate, and succinate to CHO cells can reduce accumulation of lactate and ammonium in fed-batch culture and improve cell-specific productivity and antibody titer (Zhang et al. 2020b). Xiao et al. designed continuous feeding strategy in fed-batch culture. They found that continuous feeding reduced accumulation of lactate and ammonium because of massive nutritional feed medium in a 7-L bioreactor. Finally, the production of C12 antibody was promoted (Xiao et al. 2021). In fed-batch culture, byproducts should be avoided. It is advisable for fed-batch culture to choose available feeding strategies to reduce the probability and concentration of metabolic byproducts accumulation.
Chemostat cultivation
For improving cell-specific productivity of RTPs, successful strategies require to manipulate culture temperature and glucose concentration in media. Unfortunately, changes in cell culture affect the specific growth rate, especially in both operational variables. To produce recombinant human tissue plasminogen activator (rh-tPA) in CHO cell, Vergara et al. utilized chemostat cultivation and set three groups about feeding media with 20 mM, 30 mM, and 40 mM glucose concentrations. A total of 40 mM glucose limited cell growth, but it increased cell-specific productivity of rh-tPA and cells in the G2/M phase. Furthermore, glucose consumption and lactate production rates were reduced when temperature condition was 33 °C. Vergara et al. indicated that a reduced specific growth rate together with high feed glucose rapidly improves protein productivity in CHO cell (Vergara et al. 2018).
The intensified fed-batch
In the biomanufacturing industry, intensified processes require more time to develop compared with conventional fed-batch.
Schulze et al. performed standard fed-batch (sFB) and intensified fed-batch (iFB) processes in 15 mL and 250-mL bioreactors, starting with 4% (vol / vol) feed medium A and 4% (vol / vol) feed medium B. The final glucose concentration was 5 g/L. Cell concentrations inoculated by N-1 perfusion reached 1 × 108 cells/mL, which are used for the iFB. In 15 mL bioreactors, two iFBs inoculated at 2.5 and 5 × 106 cells/mL were from N-1 perfusion. Compared with sFB process, similar titers were reached in shorter process times, but respectively, the space–time yield (STY) was dramatically increased by 16% and 36% for the 2.5 and 5 × 106 cells/mL methods. In 250-mL bioreactors, iFB inoculated at 5 × 106 cells/mL added 2.5 mM butyric acid (BA) after 48 h. Compared with iFB inoculated at 5 × 106 cells/mL without BA, KPI was found by raising the STY by 50% after BA treatment. The average cell-specific productivity was increased from 25 to 37 pg/cell/day through BA supplementation (Schulze et al. 2022a, b).
Discussion
RTPs are fast developing. About 40 novel antibodies are introduced each year. How to implement high-level expression and production of RTPs is a challenge which limits RTP drugs development. These are state-of-the-art strategies for boosting RTP production and quality, such as optimizing gene sequence, expression vector, and glycosylation (Zhang et al. 2022).
A report has shown that the biosimilar development of pembrolizumab can be directed by Quality by design (QbD) (Jaffar-Aghaei et al. 2022). QbD is an efficient but challenging approach for the development of biosimilar due to the complex relationship among process, quality, and efficacy (Zhang et al. 2020c). To ensure critical quality attributes (CQAs) about the production of mAbs, an understanding of the production process is highlighted by QbD (Gibbons et al. 2022). Jaffar-Aghaei et al. found a pharmaceutical measurement guided by QbD to undertake the Pembrolizumab biosimilar candidate PSG-024 (Keytruda®) in fed-batch culture. Currently, Keytruda® has become the ace of therapeutic mAbs (Jaffar-Aghaei et al. 2022).
Despite the fact that glucose concentration above 1 g/L had brought 10 g/L mAb titer, Handlogten et al. still pointed out that bolus feeding was defective (Handlogten et al. 2018). Recently, the final mAb titer of 4 g/L was reached by the glucose concentration of 12 g/L in fed-batch platform process (Schellenberg et al. 2022); meanwhile, the final glucose concentration was 5 g/L. This glucose feeding strategy also promoted cell growth efficiently. Cysteine greater than 2.5 mM with low cell densities resulted in counteracted oxidative stress, but Komuczki et al. presented that high cysteine concentration with a higher cell concentration can counteract oxidative stress (Komuczki et al. 2022). Wang et al. reported that an upturn in terms of the product titer was influenced by temperature shifted to 33℃ in 14-day fed-batch culture, and 100% normalized titer was set as the highest titer on day 14. Fed-batch optimization is available and nevertheless, optimizing all process parameters is impossible on account of limited resources and timeline (Wang et al. 2022).
Biosimilars will enter the markets in the context of COVID-19 (Schulze et al. 2022a, b; Tichy et al. 2022), it depends on a robust and scalable manufacturing with excellent productivity. PI is a key trend involving process strategies. Along with the advance of perfusion and other processes, fed-batch culture has been studied increasingly (MacDonald et al. 2022; Schulze et al. 2022a, b). Presently, there is still some room for improvement in fed-batch culture (Wang et al. 2022).
Summary and prospect
Overall, fed-batch culture has harvested high-yield and high-quality protein production, prolonging cell culture time. Feed medium is replenished continuously or intermittently in fed-batch culture. In recent years, fed-batch culture has made considerable progress. Feed components optimization is still essential for process development. Simultaneously, fed-batch culture should consider culture parameters, nutrient consumption and accumulation of metabolic byproducts, etc. With in-depth exploration of RTP production in CHO cells, we still take these indicators into account in the future, such as cell growth, the yield and quality of RTPs. However, fed-batch culture has defects in the aspect of process development, choosing optimal parameters is challenging, including temperature, pH, dissolved oxygen, basal and feeding medium, and additives. Exploring a series of great process parameters are constrained by limited factors. With the wide application of multi-omics, new monitoring and analysis technology, artificial intelligence together with other methods, intensified fed-batch culture will further improve the yield and quality of recombinant protein production.
Data Availability
All data included in this study are available upon request by contact with the corresponding author.
References
Aki Y, Katsumata Y, Kakihara H, Nonaka K, Fujiwara K (2021) 4-(2,5-Dimethyl-1H-pyrrol-1-yl) -N- (2,5-dioxopyrrolidin-1-yl) benzamide improves monoclonal antibody production in a Chinese hamster ovary cell culture. PLoS One 16:1–20. https://doi.org/10.1371/journal.pone.0250416
Alhuthali S, Kotidis P, Kontoravdi C (2021) Osmolality effects on CHO cell growth, cell volume, antibody productivity and glycosylation. Int J Mol Sci 22:1–19. https://doi.org/10.3390/ijms22073290
Ali AS, Raju R, Ray S, Kshirsagar R, Gilbert A, Zang L, Karger BL (2018) Lipidomics of CHO cell bioprocessing: relation to cell growth and specific productivity of a monoclonal antibody. Biotechnol J 13:e1700745. https://doi.org/10.1002/biot.201700745
Baik JY, Dahodwala H, Oduah E, Talman L, Gemmill TR, Gasimli L, Datta P, Yang B, Li G, Zhang F, Li L, Linhardt RJ, Campbell AM, Gorfien SF, Sharfstein ST (2015) Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin. Biotechnol J 10:1067–1081. https://doi.org/10.1002/biot.201400665
Bibila TA, Robinson DK (1995) In pursuit of the optimal fed-batch process for monoclonal antibody production. Biotechnol Prog 11:1–13. https://doi.org/10.1021/bp00031a001
Braasch K, Kryworuchko M, Piret JM (2021) Autophagy-inducing peptide increases CHO cell monoclonal antibody production in batch and fed-batch cultures. Biotechnol Bioeng 118:1876–1883. https://doi.org/10.1002/bit.27703
Brunner M, Doppler P, Klein T, Herwig C, Fricke J (2017) Elevated pCO2 affects the lactate metabolic shift in CHO cell culture processes. Eng Life Sci 18:204–214. https://doi.org/10.1002/elsc.201700131
Butler M (2005) Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68:283–291. https://doi.org/10.1007/s00253-005-1980-8
Chee Furng Wong D, Tin Kam Wong K, Tang Goh L, Kiat Heng C, Gek Sim Yap M (2005) Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng 89:164–177. https://doi.org/10.1002/bit.20317
Chitwood DG, Wang Q, Elliott K, Bullock A, Jordana D, Li Z, Wu C, Harcum SW, Saski CA (2021) Characterization of metabolic responses, genetic variations, and microsatellite instability in ammonia-stressed CHO cells grown in fed-batch cultures. BMC Biotechnol 21:1–16. https://doi.org/10.1186/s12896-020-00667-2
Chotigeat W, Watanapokasin Y, Mahler S, Gray PP (1994) Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology 15:217–221. https://doi.org/10.1007/BF00762396
Chung S, Tian J, Tan Z, Chen J, Zhang N, Huang Y, Vandermark E, Lee J, Borys M, Li ZJ (2019) Modulating cell culture oxidative stress reduces protein glycation and acidic charge variant formation. Mabs 11:205–216. https://doi.org/10.1080/19420862.2018.1537533
Costa AR, Rodrigues ME, Henriques M, Oliveira R, Azeredo J (2014) Feed optimization in fed-batch culture. Methods Mol Biol 1104:105–116. https://doi.org/10.1007/978-1-62703-733-4_8
Dahodwala H, Lee KH (2019) The fickle CHO: a review of the causes, implications, and potential alleviation of the CHO cell line instability problem. Curr Opin Biotechnol 60:128–137. https://doi.org/10.1016/j.copbio.2019.01.011
Domján J, Pantea E, Gyürkés M, Madarász L, Kozák D, Farkas A, Horváth B, Benkő Z, Nagy ZK, Marosi G, Hirsch E (2022) Real-time amino acid and glucose monitoring system for the automatic control of nutrient feeding in CHO cell culture using Raman spectroscopy. Biotechnol J 17(5):e2100395. https://doi.org/10.1002/biot.202100395
Eyster WT, Talwar S, Fernandez J, Foster S, Hayes J, Allen R, Reidinger S, Wan B, Ji X, Aon J, Patel P, Ritz DB (2021) Tuning monoclonal antibody galactosylation using Raman spectroscopy-controlled lactic acid feeding. Biotechnol Prog 37:e3085. https://doi.org/10.1002/btpr.3085
Fan YZ, Jimenez Del Val I, Müller C, Wagtberg Sen J, Rasmussen SK, Kontoravdi C, Weilguny D, Andersen MR (2015) Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation. Biotechnol Bioeng 112:521–535. https://doi.org/10.1002/bit.25450
Feng W, Shi JS (2020) Culture condition optimization for expression of anti-human VEGF monoclonal antibody by CHO cell. Industrial Microbiology 50:28–35. https://doi.org/10.3969/j.issn.1001-6678.2020.02.005
Fleischaker RJ, Sinskey AJ (1981) Oxygen demand and supply in cell culture. Appl Microbiol Biotechnol 12:193–197. https://doi.org/10.1007/BF00499486
Fouladiha H, Marashi SA, Torkashvand F, Mahboudi F, Lewis NE, Vaziri B (2020) A metabolic network-based approach for developing feeding strategies for CHO cells to increase monoclonal antibody production. Bioprocess Biosyst Eng 43:1381–1389. https://doi.org/10.1007/s00449-020-02332-6
Gangwar N, Mishra R, Budholiya N, Rathore AS (2021) Effect of vitamins and metal ions on productivity and charge heterogeneity of IgG1 expressed in CHO cells. Biotechnol J 16:e2000464. https://doi.org/10.1002/biot.202000464
Gélinas JF, Azizi H, Kiesslich S, Lanthier S, Perdersen J, Chahal PS, Ansorge S, Kobinger G, Gilbert R, Kamen AA (2019) Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells. Vaccine 37:6624–6632. https://doi.org/10.1016/j.vaccine.2019.09.044
Ghaffari N, Jardon MA, Krahn N, Butler M, Kennard M, Turner RFB, Gopaluni B, Piret JM (2020) Effects of cysteine, asparagine, or glutamine limitations in Chinese hamster ovary cell batch and fed-batch cultures. Biotechnol Prog 36:e2946. https://doi.org/10.1002/btpr.2946
Ghorbaniaghdam A, Chen J, Henry O, Jolicoeur M (2014) Analyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platform. PLoS ONE 9:e90832. https://doi.org/10.1371/journal.pone.0090832
Gibbons AL, Rafferty C, Robinson K, Abad M, Maslanka F, Le N, Mo J, Clark K, Madden F, Hayes R, McCarthy B, Rode C, O’Mahony J, Rea R, O’Mahony Y, Hartnett C (2022) Raman based chemometric model development for glycation and glycosylation real time monitoring in a manufacturing scale CHO cell bioreactor process. Biotechnol Prog 38:e3223. https://doi.org/10.1002/btpr.3223
Graham RJ, Bhatia H, Yoon S (2019) Consequences of trace metal variability and supplementation on Chinese hamster ovary (CHO) cell culture performance: a review of key mechanisms and considerations. Biotechnol Bioeng 116:3446–3456. https://doi.org/10.1002/bit.27140
Graham RJ, Ketcham S, Mohammad A, Bandaranayake BMB, Cao T, Ghosh B, Weaver J, Yoon S, Faustino PJ, Ashraf M, Cruz CN, Madhavarao CN (2020) Zinc supplementation improves the harvest purity of β-glucuronidase from CHO cell culture by suppressing apoptosis. Appl Microbiol Biotechnol 104:1097–1108. https://doi.org/10.1007/s00253-019-10296-1
Gupta K, Modi D, Jain R, Dandekar P (2021) A Stable CHO K1 Cell line for producing recombinant monoclonal antibody against TNF-α. Mol Biotechnol 63:828–839. https://doi.org/10.1007/s12033-021-00329-4
Ha TK, Kim D, Kim CL, Grav LM, Lee GM (2022) Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture. Biotechnol Adv 54:1–43. https://doi.org/10.1016/j.biotechadv.2021.107831
Handlogten MW, Lee-O’Brien A, Roy G (2018) Intracellular response to process optimization and impact on productivity and product aggregates for a high-titer CHO cell process. Biotechnol Bioeng 115:126–138. https://doi.org/10.1002/bit.26460
Hecklau C, Pering S, Seibel R, Schnellbaecher A, Wehsling M, Eichhorn T, Hagen JV, Zimmer A (2016) S-Sulfocysteine simplifies fed-batch processes and increases the CHO specific productivity via anti-oxidant activity. J Biotechnol 218:53–63. https://doi.org/10.1016/j.jbiotec.2015.11.022
Hernández Rodríguez T, Frahm B (2020) Design, optimization, and adaptive control of cell culture seed trains. Methods Mol Biol 2095:251–267. https://doi.org/10.1007/978-1-0716-0191-4_14
Hoang D, Galbraith S, Kuang B, Johnson A, Yoon S (2021) Characterization of Chinese hamster ovary cell culture feed media precipitate. Biotechnol Prog 37:e3188. https://doi.org/10.1002/btpr.3188
Hong JK, Nargund S, Lakshmanan M, Kyriakopoulos S, Kim DY, Ang KS, Leong D, Yang Y, Lee DY (2018) Comparative phenotypic analysis of CHO clones and culture media for lactate shift. J Biotechnol 283:97–104. https://doi.org/10.1016/j.jbiotec.2018.07.042
Horvat J, Narat M, Spadiut O (2020) The effect of amino acid supplementation in an industrial Chinese Hamster Ovary process. Biotechnol Prog 36:e3001. https://doi.org/10.1002/btpr.3001
Hou Y, Su H, Luo Z, Li M, Ma X, Ma N (2019) Nutrient optimization reduces phosphorylation and hydroxylation level on an fc-fusion protein in a CHO fed-batch process. Biotechnol J 14:e1700706. https://doi.org/10.1002/biot.201700706
Hu DD, Zhao L, Wang JQ, Fan L, Liu XP, Wang HB, Tan WS (2018) Physiological responses of Chinese hamster ovary cells to a productivity-enhancing yeast extract. J Biosci Bioeng 126:636–643. https://doi.org/10.1016/j.jbiosc.2018.05.005
Jaffar-Aghaei M, Khanipour F, Maghsoudi A, Sarvestani R, Mohammadian M, Maleki M, Havasi F, Rahmani H, Karagah AH, Kazemali MR (2022) QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®. Eur J Pharm Sci 173:106171. https://doi.org/10.1016/j.ejps.2022.106171
Jänne J, Alhonen L, Pietilä M, Keinänen TA (2004) Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem 271:877–894. https://doi.org/10.1111/j.1432-1033.2004.04009.x
Jardon MA, Sattha B, Braasch K, Leung AO, Côté HC, Butler M, Gorski SM, Piret JM (2012) Inhibition of glutamine-dependent autophagy increases t-PA production in CHO cell fed-batch processes. Biotechnol Bioeng 109:1228–1238. https://doi.org/10.1002/bit.24393
Kamachi Y, Omasa T (2018) Development of hyper osmotic resistant CHO host cells for enhanced antibody production. J Biosci Bioeng 125:470–478. https://doi.org/10.1016/j.jbiosc.2017.11.002
Kaplon H, Muralidharan M, Schneider Z, Reichert JM (2020) Antibodies to watch in 2020. MAbs 12:1703531. https://doi.org/10.1080/19420862.2019.1703531
Karengera E, Robotham A, Kelly J, Durocher Y, De Crescenzo G, Henry O (2018) Concomitant reduction of lactate and ammonia accumulation in fed-batch cultures: impact on glycoprotein production and quality. Biotechnol Prog 34:494–504. https://doi.org/10.1002/btpr.2607
Kelley B (2009) Industrialization of mAb production technology: the bioprocessing industry at a crossroads. Mabs 1:443–452. https://doi.org/10.4161/mabs.1.5.9448
Kirsch BJ, Bennun SV, Mendez A, Johnson AS, Wang H, Qiu H, Li N, Lawrence SM, Bak H, Betenbaugh MJ (2022) Metabolic analysis of the asparagine and glutamine dynamics in an industrial Chinese hamster ovary fed-batch process. Biotechnol Bioeng 119:807–819. https://doi.org/10.1002/bit.27993
Komuczki D, Stadermann A, Bentele M, Unsoeld A, Grillari J, Mueller MM, Paul A, Fischer S (2022) High cysteine concentrations in cell culture media lead to oxidative stress and reduced bioprocess performance of recombinant CHO cells. Biotechnol J 17:e2200029. https://doi.org/10.1002/biot.202200029
Konakovsky V, Clemens C, Müller MM, Bechmann J, Berger M, Schlatter S, Herwig C (2016) Metabolic control in mammalian fed-batch cell cultures for reduced lactic acid accumulation and improved process robustness. Bioengineering (basel) 3:5. https://doi.org/10.3390/bioengineering3010005
Kong JT, Zhuang YP, Guo MJ (2020) Enhancement of Anti-CD20 monoclonal antibody expression by CHO based on DOE and amino acid supplemental strategy. China Biotechnology 40:41–48. https://doi.org/10.13523/j.cb.2009009
Kou TC, Fan L, Zhou Y, Ye ZY, Liu XP, Zhao L, Tan WS (2011) Detailed understanding of enhanced specific productivity in Chinese hamster ovary cells at low culture temperature. J Biosci Bioeng 111:365–369. https://doi.org/10.1016/j.jbiosc.2010.11.016
Kozma B, Salgó A, Gergely S (2018) Comparison of multivariate data analysis techniques to improve glucose concentration prediction in mammalian cell cultivations by Raman spectroscopy. J Pharm Biomed Anal 158:269–279. https://doi.org/10.1016/j.jpba.2018.06.005
Kuwae S, Miyakawa I, Doi T (2018) Development of a chemically defined platform fed-batch culture media for monoclonal antibody-producing CHO cell lines with optimized choline content. Cytotechnology 70:939–948. https://doi.org/10.1007/s10616-017-0185-1
Lalonde ME, Durocher Y (2017) Therapeutic glycoprotein production in mammalian cells. J Biotechnol 125:128–140. https://doi.org/10.1016/j.jbiotec.2017.04.028
Lee JH, Reier J, Heffner KM, Barton C, Spencer D, Schmelzer AE, Venkat R (2017a) Production and characterization of active recombinant human factor II with consistent sialylation. Biotechnol Bioeng 114:1991–2000. https://doi.org/10.1002/bit.26317
Lee JH, Jeong YR, Kim YG, Lee GM (2017b) Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile. Biotechnol Bioeng 114:1721–1732. https://doi.org/10.1002/bit.26284
Li J, Wong CL, Vijayasankaran N, Hudson T, Amanullah A (2012) Feeding lactate for CHO cell culture processes: impact on culture metabolism and performance. Biotechnol Bioeng 109:1173–1186. https://doi.org/10.1002/bit.24389
Li WF, Fan ZL, Lin Y, Wang TY (2021) Serum-free medium for recombinant protein expression in Chinese hamster ovary cells. Front Bioeng Biotechnol 9:1–11. https://doi.org/10.3389/fbioe.2021.646363
Lu F, Toh PC, Burnett I, Li F, Hudson T, Amanullah A, Li J (2013) Automated dynamic fed-batch process and media optimization for high productivity cell culture process development. Biotechnol Bioeng 110:191–205. https://doi.org/10.1002/bit.24602
Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC (2020) Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 27:1. https://doi.org/10.1186/s12929-019-0592-z
MacDonald MA, Nöbel M, Roche Recinos D, Martínez VS, Schulz BL, Howard CB, Baker K, Shave E, Lee YY, Marcellin E, Mahler S, Nielsen LK, Munro T (2022) Perfusion culture of Chinese hamster ovary cells for bioprocessing applications. Crit Rev Biotechnol 42:1099–1115. https://doi.org/10.1080/07388551.2021.1998821
Mahé A, Martiné A, Fagète S, Girod PA (2022) Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production. Bioprocess Biosyst Eng 45:297–307. https://doi.org/10.1007/s00449-021-02657-w
McHugh KP, Xu J, Aron KL, Borys MC, Li ZJ (2020) Effective temperature shift strategy development and scale confirmation for simultaneous optimization of protein productivity and quality in Chinese hamster ovary cells. Biotechnol Prog 36:e2959. https://doi.org/10.1002/btpr.2959
Mellahi K, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O (2019) Process intensification for the production of rituximab by an inducible CHO cell line. Bioprocess Biosyst Eng 42:711–725. https://doi.org/10.1007/s00449-019-02075-z
Michl J, Park KC, Swietach P (2019) Evidence-based guidelines for controlling pH in mammalian live-cell culture systems. Commun Biol 2:144. https://doi.org/10.1038/s42003-019-0393-7
Moore A, Mercer J, Dutina G, Donahue CJ, Bauer KD, Mather JP, Etcheverry T, Ryll T (1997) Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues. Cytotechnology 23:47–54. https://doi.org/10.1023/A:1007919921991
Pan X, Streefland M, Dalm C, Wijffels RH, Martens DE (2017) Selection of chemically defined media for CHO cell fed-batch culture processes. Cytotechnology 69:39–56. https://doi.org/10.1007/s10616-016-0036-5
Qin J, Wu X, Xia Z, Huang Z, Zhang Y, Wang Y, Fu Q, Zheng C (2019) The effect of hyperosmolality application time on production, quality, and biopotency of monoclonal antibodies produced in CHO cell fed-batch and perfusion cultures. Appl Microbiol Biotechnol 103:1217–1229. https://doi.org/10.1007/s00253-018-9555-7
Restelli V, Wang MD, Huzel N, Ethier M, Perreault H, Butler M (2006) The effect of dissolved oxygen on the production and the glycosylation profile of recombinant human erythropoietin produced from CHO cells. Biotechnol Bioeng 94:481–494. https://doi.org/10.1002/bit.20875
Rish AJ, Drennen JK, Anderson CA (2022) Metabolic trends of Chinese hamster ovary cells in biopharmaceutical production under batch and fed-batch conditions. Biotechnol Prog 38:e3320. https://doi.org/10.1002/btpr.3220
Ritacco FV, Wu Y, Khetan A (2018) Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: history, key components, and optimization strategies. Biotechnol Prog 34:1407–1426. https://doi.org/10.1002/btpr.2706
Romanova N, Schelletter L, Hoffrogge R, Noll T (2022) Hyperosmolality in CHO cell culture: effects on the proteome. Appl Microbiol Biotechnol 106:2569–2586. https://doi.org/10.1007/s00253-022-11861-x
Schellenberg J, Nagraik T, Wohlenberg OJ, Ruhl S, Bahnemann J, Scheper T, Solle D (2022) Stress-induced increase of monoclonal antibody production in CHO cells. Eng Life Sci 22:427–436. https://doi.org/10.1002/elsc.202100062
Schmid A, Kreidl E, Bertschinger M, Vetsch P (2022) Benchtop bioreactors in mammalian cell culture: overview and guidelines. Methods Mol Biol 2436:1–15. https://doi.org/10.1007/7651_2021_441
Schmidt C, Wehsling M, Le Mignon M, Wille G, Rey Y, Schnellbaecher A, Zabezhinsky D, Fischer M, Zimmer A (2021) Lactoyl leucine and isoleucine are bioavailable alternatives for canonical amino acids in cell culture media. Biotechnol Bioeng 118:3395–3408. https://doi.org/10.1002/bit.27755
Schneider A, Gorr IH, Larraillet V, Frensing T, Popp O (2019) Reduction of IL-2 fragmentation during manufacturing of a novel immunocytokine by DoE process optimization. Biotechnol Bioeng 116:2503–2513. https://doi.org/10.1002/bit.27090
Schulze M, Niemann J, Wijffels RH, Matuszczyk J, Martens DE (2022a) Rapid intensification of an established CHO cell fed-batch process. Biotechnol Prog 38:e3213. https://doi.org/10.1002/btpr.3213
Schulze M, Kumar Y, Rattay M, Niemann J, Wijffels RH, Martens DE (2022b) Transcriptomic analysis reveals mode of action of butyric acid supplementation in an intensified CHO cell fed-batch process. Biotechnol Bioeng 119:2359–2373. https://doi.org/10.1002/bit.28150
Sellick CA, Croxford AS, Maqsood AR, Stephens GM, Westerhoff HV, Goodacre R, Dickson AJ (2015) Metabolite profiling of CHO cells: Molecular reflections of bioprocessing effectiveness. Biotechnol J 10:1434–1445. https://doi.org/10.1002/biot.201400664
Spens E, Häggström L (2007) Defined protein and animal component-free NS0 fed-batch culture. Biotechnol Bioeng 98:1183–1194. https://doi.org/10.1002/bit.21509
Stach CS, McCann MG, O’Brien CM, Le TS, Somia N, Chen X, Lee K, Fu HY, Daoutidis P, Zhao L, Hu WS, Smanski M (2019) Model-driven engineering of N-linked glycosylation in chinese hamster ovary cells. ACS Synth Biol 8:2524–2535. https://doi.org/10.1021/acssynbio.9b00215
Stiefel F, Fischer S, Sczyrba A, Otte K, Hesse F (2016) miRNA profiling of high, low and non-producing CHO cells during biphasic fed-batch cultivation reveals process relevant targets for host cell engineering. J Biotechnol 225:31–43. https://doi.org/10.1016/j.jbiotec.2016.03.028
Sun JJ, Wang G, Zhao QH, Li GL (2021) Research progress on key technologies of preparing recombinant antibodies from mammalian CHO cells. Chin Med Biotechnol 16:348–353. https://doi.org/10.3969/j.issn.1673-713X.2021.04.010
Takagi Y, Kikuchi T, Wada R, Omasa T (2017) The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside. Cytotechnology 69:511–521. https://doi.org/10.1007/s10616-017-0066-7
Tichy EM, Hoffman JM, Suda KJ, Rim MH, Tadrous M, Cuellar S, Clark JS, Ward J, Schumock GT (2022) National trends in prescription drug expenditures and projections for 2022. Am J Health Syst Pharm 79:1158–1172. https://doi.org/10.1093/ajhp/zxac102
Torres M, Altamirano C, Dickson AJ (2018) Process and metabolic engineering perspectives of lactate production in mammalian cell cultures. Curr Opin Chem Eng 22:184–190. https://doi.org/10.1016/j.coche.2018.10.004
Torres M, Akhtar S, McKenzie EA, Dickson AJ (2021) Temperature down-shift modifies expression of UPR-/ERAD-related genes and enhances production of a chimeric fusion protein in CHO cells. Biotechnol J 16:1–11. https://doi.org/10.1002/biot.202000081
Ventini DC, Damiani R, Sousa AP, de Oliveira JE, Peroni CN, Ribela MT, Bartolini P, Tonso A, Soares CR, Pereira CA (2011) Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH. Appl Biochem Biotechnol 164:401–409. https://doi.org/10.1007/s12010-010-9143-5
Vergara M, Torres M, Müller A, Avello V, Acevedo C, Berrios J, Reyes JG, Valdez-Cruz NA, Altamirano C (2018) High glucose and low specific cell growth but not mild hypothermia improve specific r-protein productivity in chemostat culture of CHO cells. PLoS One 13:e0202098. https://doi.org/10.1371/journal.pone.0202098
Vijayasankaran N, Varma S, Yang Y, Mun M, Arevalo S, Gawlitzek M, Swartz T, Lim A, Li F, Zhang B, Meier S, Kiss R (2013) Effect of cell culture medium components on color of formulated monoclonal antibody drug substance. Biotechnol Prog 29:1270–1277. https://doi.org/10.1002/btpr.1772
Wang Z, Wang C, Chen G (2022) Kinetic modeling: a tool for temperature shift and feeding optimization in cell culture process development. Protein Expr Purif 198:106130. https://doi.org/10.1016/j.pep.2022.106130
Weng Z, Jin J, Shao C, Li H (2020) Reduction of charge variants by CHO cell culture process optimization. Cytotechnology 72:259–269. https://doi.org/10.1007/s10616-020-00375-x
Wilkens CA, Altamirano C, Gerdtzen ZP (2011) Comparative metabolic analysis of lactate for cho cells in glucose and galactose. Biotechnol Bioprocess Eng 16:714–724. https://doi.org/10.1007/s12257-010-0409-0
Wlaschin KF, Hu WS (2007) Engineering cell metabolism for high-density cell culture via manipulation of sugar transport. J Biotechnol 131:168–176. https://doi.org/10.1016/j.jbiotec.2007.06.006
Xiao Z, Fan L, Tan WS (2019) Galactose feeding in CHO cell culture process: the impacts on the cell growth, metabolism and glycosylation of fc fusion protein. Biotechnol Bulletin 35:138–145. https://doi.org/10.13560/j.cnki.biotech.bull.1985.2019-0138
Xiao S, Ahmed W, Mohsin A, Guo M (2021) Continuous feeding reduces the generation of metabolic byproducts and increases antibodies expression in Chinese hamster ovary-K1 cells. Life (basel) 11:1–12. https://doi.org/10.3390/life11090945
Xie L, Wang DI (1994a) Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. Biotechnol Bioeng 43:1175–1189. https://doi.org/10.1002/bit.260431123
Xie L, Wang DI (1994b) Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor. Cytotechnology 15:17–29. https://doi.org/10.1007/BF00762376
Xing Z, Kenty B, Koyrakh I, Borys M, Pan SH, Li ZJ (2011) Optimizing amino acid composition of CHO cell culture media for a fusion protein production. Process Biochem 46:1423–1429. https://doi.org/10.1016/j.procbio.2011.03.014
Xu S, Hoshan L, Chen H (2016) Improving lactate metabolism in an intensified CHO culture process: productivity and product quality considerations. Bioprocess Biosyst Eng 39:1689–1702. https://doi.org/10.1007/s00449-016-1644-3
Yang M, Butler M (2000) Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnol Bioeng 68:370–380. https://doi.org/10.1002/(SICI)1097-0290(20000520)68:4%3c370:AIDBIT2%3e3.0.CO;2-K
Yao T, Asayama Y (2017) Animal-cell culture media: history, characteristics, and current issues. Reprod Med Biol 16:99–117. https://doi.org/10.1002/rmb2.12024
Yuan Y, Bian YL, Zhang BH, Zhu JW (2020) Establishment of FUT8 knockout CHO-S cell line with stable expression of Anti-HER2 monoclonal antibody. Chin J Pharm 51:69–74. https://doi.org/10.16522/j.cnki.cjph.2020.01.008
Zagari F, Jordan M, Stettler M, Broly H, Wurm FM (2013) Lactate metabolism shift in CHO cell culture: the role of mitochondrial oxidative activity. N Biotechnol 30:238–245. https://doi.org/10.1016/j.nbt.2012.05.021
Zhang J, Robinson D, Salmon P (2006) A novel function for selenium in biological system: selenite as a highly effective iron carrier for Chinese hamster ovary cell growth and monoclonal antibody production. Biotechnol Bioeng 95:1188–1197. https://doi.org/10.1002/bit.21081
Zhang H, Wang H, Liu M, Zhang T, Zhang J, Wang X, Xiang W (2013) Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody. Cytotechnology 65:363–378. https://doi.org/10.1007/s10616-012-9488-4
Zhang L, Castan A, Stevenson J, Chatzissavidou N, Vilaplana F, Chotteau V (2019) Combined effects of glycosylation precursors and lactate on the glycoprofile of IgG produced by CHO cells. J Biotechnol 289:71–79. https://doi.org/10.1016/j.jbiotec.2018.11.004
Zhang W, Liu X, Tang H, Zhang X, Zhou Y, Fan L, Wang H, Tan WS, Zhao L (2020a) Investigation into the impact of tyrosine on the product formation and quality attributes of mAbs in rCHO cell cultures. Appl Microbiol Biotechnol 104:6953–6966. https://doi.org/10.1007/s00253-020-10744-3
Zhang X, Jiang R, Lin H, Xu S (2020b) Feeding tricarboxylic acid cycle intermediates improves lactate consumption and antibody production in Chinese hamster ovary cell cultures. Biotechnol Prog 36:e2975. https://doi.org/10.1002/btpr.2975
Zhang E, Xie L, Qin P, Lu L, Xu Y, Gao W, Wang L, Xie MH, Jiang W, Liu S (2020c) Quality by design-based assessment for analytical similarity of adalimumab biosimilar HLX03 to humira®. AAPS J 22:69. https://doi.org/10.1208/s12248-020-00454-z
Zhang JH, Shan LL, Liang F, Du CY, Li JJ (2022) Strategies and considerations for improving recombinant antibody production and quality in chinese hamster ovary cells. Front Bioeng Biotechnol 10:856049. https://doi.org/10.3389/fbioe.2022.85604
Zhu MM, Goyal A, Rank DL, Gupta SK, Vanden Boom T, Lee SS (2005) Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: a case study. Biotechnol Prog 21:70–77. https://doi.org/10.1021/bp049815s
Zou M, Zhou ZW, Fan L, Zhang WJ, Zhao L, Liu XP, Wang HB, Tan WS (2020) A novel method based on nonparametric regression with a Gaussian kernel algorithm identifies the critical components in CHO media and feed optimization. J Ind Microbiol Biotechnol 47:63–72. https://doi.org/10.1007/s10295-019-02248-5
Funding
This work was funded by National Natural Science Foundation of China (No.32101232), and Basic Research Foundation of Key Scientific Research of Universities in Henan Province (No. 20zx013).
Author information
Authors and Affiliations
Contributions
WJX and TYW wrote and designed the manuscript; YL and CLM edited the manuscript; JYP revised this manuscript; TYW edited the review content. TYW and YL funded this manuscript.
Corresponding author
Ethics declarations
Human and animal rights and informed consent
This paper does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, WJ., Lin, Y., Mi, CL. et al. Progress in fed-batch culture for recombinant protein production in CHO cells. Appl Microbiol Biotechnol 107, 1063–1075 (2023). https://doi.org/10.1007/s00253-022-12342-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-022-12342-x